Roland Zemla

Roland Zemla

Auto-generated profile, based on publicly available information

Roland Zemla

Neuroscience Institute, New York University, New York, NY 10016, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2019 in Science
Verified
Journal Article
Closed access
CMChristopher J. Magnus
Christopher J. Magnus
PLPeter H. Lee
Peter H. Lee
JBJordi Bonaventura
Jordi Bonaventura
RZRoland Zemla
Roland Zemla
JGJuan L. Gomez
Juan L. Gomez
SSScott M. Sternson
Scott M. Sternson
Improved agonists for chemogenetics: Targeting ligand-responsive receptors to specific groups of cells, a strategy known as chemogenetics, is a powerful tool in many neurological applications. There is increasing interest in extending these tools for human treatment. Magnus et al. designed chemogenetic ion channels that improve currently available systems and are activated by the clinically used antismoking drug varenicline. They engineered a ligand-binding domain less responsive to endogenous signals and identified agonists that function at nanomolar concentrations. The combination of drug and introduced channels transiently silenced neurons, with slow but effective washout, and induced behavioral changes in animal models after brain administration. Science , this issue p. eaav5282